Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Thermo Fisher Scientific    TMO

THERMO FISHER SCIENTIFIC

(TMO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/26/2020 10/27/2020 10/28/2020 10/29/2020 10/30/2020 Date
482.43(c) 489.3(c) 476.71(c) 471.88(c) 473.12(c) Last
1 310 888 1 332 107 1 673 269 1 330 140 1 242 269 Volume
+0.47% +1.42% -2.57% -1.01% +0.26% Change
More quotes
Financials (USD)
Sales 2020 30 615 M - -
Net income 2020 5 799 M - -
Net Debt 2020 12 098 M - -
P/E ratio 2020 32,4x
Yield 2020 0,18%
Sales 2021 32 500 M - -
Net income 2021 6 253 M - -
Net Debt 2021 6 883 M - -
P/E ratio 2021 29,9x
Yield 2021 0,20%
Capitalization 187 B 187 B -
EV / Sales 2020 6,49x
EV / Sales 2021 5,96x
Nbr of Employees 75 000
Free-Float 90,6%
More Financials
Company
Thermo Fisher Scientific specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (65.4%). Moreover, the group proposes chemical products (acid, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; -... 
More about the company
Notations Surperformance© of Thermo Fisher Scientific
Trading Rating : Investor Rating :
More Ratings
All news about THERMO FISHER SCIENTIFIC
01:17pTHERMO FISHER SCIENTIFIC : signs Partnership Agreement with the new Terasaki Inn..
AQ
01:17pTHERMO FISHER SCIENTIFIC : Extends Collaboration to Advance Biopharmaceutical Di..
AQ
10:37aTHERMO FISHER SCIENTIFIC : Management's Discussion and Analysis of Financial Con..
AQ
10/28THERMO FISHER SCIENTIFIC : Expands Direct-to-Patient Clinical Trials Service Off..
AQ
10/22THERMO FISHER SCIENTIFIC : Expands COVID-19 Response by Adding Manufacturing Cap..
PU
10/22THERMO FISHER SCIENTIFIC : Reports Third Quarter 2020 Results
AQ
10/21THERMO FISHER SCIENTIFIC : Expects 2020 Revenue to Grow 20%
DJ
10/21THERMO FISHER SCIENTIFIC : 3Q Profit, Sales Rise
DJ
10/21THERMO FISHER SCIENTIFIC INC. : Results of Operations and Financial Condition, F..
AQ
10/21THERMO FISHER : 3Q Earnings Snapshot
AQ
10/21THERMO FISHER SCIENTIFIC : Reports Third Quarter 2020 Results
PR
10/20THERMO FISHER SCIENTIFIC : Increases Availability of COVID-19 Testing with Sampl..
AQ
10/19THERMO FISHER SCIENTIFIC : Increases Availability of COVID-19 Testing with Sampl..
PR
10/19Iconovo recruits for increased customer focus and delivery of customer projec..
AQ
10/19Eva Walde strengthens Senzime's Board of Directors
AQ
More news
News in other languages on THERMO FISHER SCIENTIFIC
10/28Qiagen hebt Prognose wegen steigender Nachfrage nach Corona-Tests
10/21Déjà pliée, cette élection ?
10/21EN DIRECT DES MARCHES : Vivendi, Vinci, Nestlé, Iberdrola, Ericsson, Netflix, Sn..
10/16THERMO FISHER SCIENTIFIC : publication des résultats trimestriels
10/16THERMO FISHER SCIENTIFIC : Veröffentlichung des Quartalsergebnisses
More news
Stock Trading Strategies
THERMO FISHER SCIENTIFIC - 10/23
The trend should regain control
BUY
More Stock Trading Analysis
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | TMO | US8835561023 | MarketScreener
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 501,65 $
Last Close Price 473,12 $
Spread / Highest target 16,2%
Spread / Average Target 6,03%
Spread / Lowest Target -18,8%
EPS Revisions
Managers
NameTitle
Marc N. Casper Chairman, President & Chief Executive Officer
Mark P. Stevenson Chief Operating Officer & Executive Vice President
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Scott M. Sperling Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
THERMO FISHER SCIENTIFIC45.63%186 671
DANAHER CORPORATION49.90%163 437
INTUITIVE SURGICAL, INC.16.09%80 676
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.112.64%71 519
BOSTON SCIENTIFIC CORPORATION-25.92%47 928
ILLUMINA, INC.-5.08%46 089